MedTrace Logo

Marine Oils and Arthritis

NCT00805116 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2016-05-09

No results posted yet for this study

Summary

NSAIDS are associated with adverse GI effects and COX-2 inhibitors have cardiovascular risk. Long-term oral supplementation with fish oil reduce e.g. joint pain in rheumatoid arthritis (R.A) patients, with reduced need for NSAIDS, in addition to being cardioprotective. The aim is to investigate if 4 month supplementation of 15 ml/day of whale blubber oil compared with cod liver oil reduce the intensity of joint pain in patients with R.A (primary outcome). Patients are assessed at inclusion and after study (4 months) during routine polyclinical visit. Patients are called for interview after 6 and 12 weeks. Secondary outcomes are e.g. morning stiffness, quality of life and functional level

Conditions

Interventions

DIETARY_SUPPLEMENT

Whale blubber oil

15 ml/day for 4 months, divided on dosage morning and evening, orally.

DIETARY_SUPPLEMENT

Cod liver oil

15 ml/day for 4 months, divided on dosage morning and evening, taken orally

Sponsors & Collaborators

  • National Institute of Nutrition and Seafood Research, Norway

    lead OTHER_GOV

Principal Investigators

  • Livar Frøyland, Dr · NIFES

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2009-10-31
Completion
2009-10-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00805116 on ClinicalTrials.gov